Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9868705
SERIAL NO

15023159

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides tetra-substituted cyclobutane inhibitors of Androgen Receptor Action, and methods of using such inhibitors, for the treatment of hormone-refractory cancers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • DUKE UNIVERSITY;THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carlson, Kathryn E Champaign, US 1 0
Gunther, Jillian Houston, US 1 0
Katzenellenbogen, John Urbana, US 4 2
Martin, Teresa Champaign, US 3 0
McDonnell, Donald Chapel Hill, US 2 0
Norris, John D Raleigh, US 2 0
Parent, Alexander Medford, US 1 0
Pollock, Julie Henrick, US 3 49

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 16, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 16, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00